4S2M
Crystal Structure of OXA-163 complexed with iodide in the active site
Summary for 4S2M
Entry DOI | 10.2210/pdb4s2m/pdb |
Related | 4S2L |
Descriptor | Beta-lactamase, IODIDE ION (3 entities in total) |
Functional Keywords | globular, hydrolase |
Biological source | Enterobacter cloacae |
Total number of polymer chains | 4 |
Total formula weight | 112366.41 |
Authors | Stojanoski, V.,Hu, L.,Palzkill, T.G.,Prasad, B. (deposition date: 2015-01-21, release date: 2015-07-22, Last modification date: 2023-09-20) |
Primary citation | Stojanoski, V.,Chow, D.C.,Fryszczyn, B.,Hu, L.,Nordmann, P.,Poirel, L.,Sankaran, B.,Prasad, B.V.,Palzkill, T. Structural Basis for Different Substrate Profiles of Two Closely Related Class D beta-Lactamases and Their Inhibition by Halogens. Biochemistry, 54:3370-3380, 2015 Cited by PubMed Abstract: OXA-163 and OXA-48 are closely related class D β-lactamases that exhibit different substrate profiles. OXA-163 hydrolyzes oxyimino-cephalosporins, particularly ceftazidime, while OXA-48 prefers carbapenem substrates. OXA-163 differs from OXA-48 by one substitution (S212D) in the active-site β5 strand and a four-amino acid deletion (214-RIEP-217) in the loop connecting the β5 and β6 strands. Although the structure of OXA-48 has been determined, the structure of OXA-163 is unknown. To further understand the basis for their different substrate specificities, we performed enzyme kinetic analysis, inhibition assays, X-ray crystallography, and molecular modeling. The results confirm the carbapenemase nature of OXA-48 and the ability of OXA-163 to hydrolyze the oxyimino-cephalosporin ceftazidime. The crystal structure of OXA-163 determined at 1.72 Å resolution reveals an expanded active site compared to that of OXA-48, which allows the bulky substrate ceftazidime to be accommodated. The structural differences with OXA-48, which cannot hydrolyze ceftazidime, provide a rationale for the change in substrate specificity between the enzymes. OXA-163 also crystallized under another condition that included iodide. The crystal structure determined at 2.87 Å resolution revealed iodide in the active site accompanied by several significant conformational changes, including a distortion of the β5 strand, decarboxylation of Lys73, and distortion of the substrate-binding site. Further studies showed that both OXA-163 and OXA-48 are inhibited in the presence of iodide. In addition, OXA-10, which is not a member of the OXA-48-like family, is also inhibited by iodide. These findings provide a molecular basis for the hydrolysis of ceftazidime by OXA-163 and, more broadly, show how minor sequence changes can profoundly alter the active-site configuration and thereby affect the substrate profile of an enzyme. PubMed: 25938261DOI: 10.1021/acs.biochem.5b00298 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.87 Å) |
Structure validation
Download full validation report